Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04150640
Title P2 5-FU, Oxaliplatin & Liposomal Irinotecan (Nal-IRI) in 1st Line Advanced Esophageal & Gastric
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

gastroesophageal adenocarcinoma

Therapies

Fluorouracil + MM-398 + Oxaliplatin

Fluorouracil + MM-398 + Oxaliplatin + Trastuzumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Wisconsin Carbone Cancer Center Recruiting Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field